Literature DB >> 718156

Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538.

E J Goldstein, V L Sutter, S M Finegold.   

Abstract

The susceptibilities of 284 anaerobic bacteria, including 55 strains of the Bacteroides fragilis group, were determined by an agar dilution technique to metronidazole and two newer nitroimidazoles, ornidazole and SC-28538. All three agents showed marked in vitro activity against virtually all anaerobic bacteria tested. At concentrations </=1 mug/ml, SC-28538 was significantly more active than either metronidazole or ornidazole. At concentrations of >1 mug/ml, the activities of all three agents were comparable. Propionibacterium and Actinomyces showed significant resistance to all three agents. Anaerobic and microaerophilic members of the genus Streptococcus were also often resistant, in contrast to Peptococcus and Peptostreptococcus strains. In addition, the bactericidal activities of ornidazole and SC-28538 were determined against 27 strains of the B. fragilis group by a broth dilution technique. The minimal inhibitory and minimal bactericidal concentrations of each agent were very close. At concentrations of </=0.5 mug/ml, SC-28538 showed greater bactericidal activity; at concentrations of >/=2 mug/ml, the activies of both agents were similar.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 718156      PMCID: PMC352515          DOI: 10.1128/AAC.14.4.609

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Treatment with metronidazole of three patients with serious infections due to Bacteroides fragilis.

Authors:  H R Ingham; G E Rich; J B Selkon; J H Hale; C M Roxby; M J Betty; R W Johnson; P R Uldall
Journal:  J Antimicrob Chemother       Date:  1975-06       Impact factor: 5.790

2.  [The activity of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (R. P. 8823) against experimental Trichomonas vaginalis infections].

Authors:  C COSAR; L JULOU
Journal:  Ann Inst Pasteur (Paris)       Date:  1959-02

3.  [Treatment of meningitis caused by Bacteroides fragilis with injections of ornidazole].

Authors:  M Cadoz; B Deborne; C Lafaix; O Langlois-Zantain; A Dublanchet
Journal:  Nouv Presse Med       Date:  1977 Jul 2-9

4.  Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods.

Authors:  J Wust
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

5.  Bacteroides fragilis resistant to metronidazole after long-term therapy.

Authors:  H R Ingham; S Eaton; C W Venables; P C Adams
Journal:  Lancet       Date:  1978-01-28       Impact factor: 79.321

6.  Synthesis of antimicrobial nitroimidazolyl 2-sulfides, -sulfoxides, and -sulfones.

Authors:  R C Tweit; E M Kreider; R D Muir
Journal:  J Med Chem       Date:  1973-10       Impact factor: 7.446

7.  Bacteriological study of otogenic cerebral abscesses: chemotherapeutic role of metronidazole.

Authors:  H R Ingham; J B Slekon; C M Roxby
Journal:  Br Med J       Date:  1977-10-15

8.  Ornidazole: a new antiprotozoal compound for treatment of Trichomonas vaginalis infection.

Authors:  M Sköld; H Gnarpe; L Hillström
Journal:  Br J Vener Dis       Date:  1977-02

9.  Susceptibility of anaerobic bacteria to 23 antimicrobial agents.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

10.  Nitroimidazoles with antibacterial activity against Neisseria gonorrhoeae.

Authors:  R C Tweit; R D Muir; S Ziecina
Journal:  J Med Chem       Date:  1977-12       Impact factor: 7.446

View more
  11 in total

1.  Efficacy and safety of morinidazole in pelvic inflammatory disease: results of a multicenter, double-blind, randomized trial.

Authors:  C Cao; A Luo; P Wu; D Weng; H Zheng; S Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-06       Impact factor: 3.267

2.  Comparative in vitro activity of ceftriaxone against anaerobic bacteria.

Authors:  R D Rolfe; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

3.  Experience with a novel selective medium for isolation of Actinomyces spp. from medical and dental specimens.

Authors:  R Lewis; D McKenzie; J Bagg; A Dickie
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

4.  Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.

Authors:  W E Owens; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

5.  Detection of anaerobic odontogenic infections by fluorine-18 fluoromisonidazole.

Authors:  R S Liu; L S Chu; S H Yen; C P Chang; K L Chou; L C Wu; C W Chang; M T Lui; K Y Chen; S H Yeh
Journal:  Eur J Nucl Med       Date:  1996-10

6.  Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.

Authors:  R D Rolfe; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

7.  Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics.

Authors:  L Dubreuil; J Devos; C Neut; C Romond
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

8.  Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.

Authors:  H Merdjan; A Baumelou; B Diquet; O Chick; E Singlas
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

9.  Studies on the disposition of a 5-nitroimidazole in laboratory animals.

Authors:  A Barrow; S R Burford; T J Forrest; A J Hawkins; D A Rose; P M Stevens; C W Vose; C M Walls
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Apr-Jun       Impact factor: 2.441

10.  Susceptibility of anaerobic bacteria to nine antimicrobial agents and demonstration of decreased susceptibility of Clostridium perfringens to penicillin.

Authors:  T J Marrie; E V Haldane; C A Swantee; E A Kerr
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.